Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B7CW
|
|||
| Drug Name |
PMID26413912-Compound-84
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BIAL-Portela & Ca., S.A
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H15F2N3O5
|
|||
| Canonical SMILES |
COCCOC1=C(C=CC(=C1)N2C(=O)OC(=N2)OC3=C(C=C(C=C3)F)F)N
|
|||
| InChI |
1S/C17H15F2N3O5/c1-24-6-7-25-15-9-11(3-4-13(15)20)22-17(23)27-16(21-22)26-14-5-2-10(18)8-12(14)19/h2-5,8-9H,6-7,20H2,1H3
|
|||
| InChIKey |
AYJCMQZJZQQNKN-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Fatty-acid amide hydrolase 1 (FAAH1) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| Fatty-acid amide hydrolase 1 (FAAH1) | Target's Patent Info | [1] | ||
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.